Did You Know...
...that the Band-Aid Bandage was invented by a Johnson & Johnson employee whose wife had cut herself? Earl Dickson's wife was rather accident prone, so he set out to develop a bandage that she could apply without help. He placed a small piece of gauze in the center of a small piece of surgical tape, and what we know today as the Band Aid bandage was born!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8163701 | Prodrugs of active agents Disclosed herein are prodrugs of active agents which contain at least one amine, phenol, carboxylic acid, or thiol functionality. Also disclosed herein are methods of making prodrugs of active agents, pharmaceutical compositions of prodrugs of active agents and meth... | 04/24/2012 |
| 7199160 | Antiobestic agents and health foods Antiobestic agents and health foods containing as the active ingredient substances having an effect of adsorbing bile acid in the digestive tract, an effect of inhibiting intestinal circulation or an effect of inhibiting the absorption of exogenous lipids typified b... | 04/03/2007 |
| 7153497 | Controlled dissolution of active ingredients A dosage form comprising a resin/resinate combination is described. Said dosage form allows optimization of the release rate profile of active ingredients. ... | 12/26/2006 |
| 7147845 | Antimicrobial silver ion complex resinates The present invention relates to novel antimicrobial silver ion complex resinates. More particularly, the present invention contemplates silver ion complex resinate compositions comprising a silver-thiosulfate ion complex loaded onto an organic anion exchange resin.... | 12/12/2006 |
| 7087223 | Preventives and/or remedies for hyperphosphatemia Provided in a phosphate ion adsorbent containing a weakly basic anion exchange resin as an active ingredient which aims at providing preventives and/or remedies for hyperphosphatemia having a high selectivity for the adsorption of phosphate ion and showing an effect... | 08/08/2006 |
| 7014846 | Phosphate-binding polymers for oral administration Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia. ... | 03/21/2006 |
| 6858203 | Method of making phosphate-binding polymers for oral administration Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia. ... | 02/22/2005 |
| 6692734 | N,O-amidomalonate platinum complexes The present invention relates to purified platinum complexes in which platinum is coordinated to form a single N,O- or O,O-chelate of an amidomalonate. The chelates, and pharmaceutically acceptable formulations thereof, are useful for the treatment of can... | 02/17/2004 |
| 6673338 | Nitric oxide-releasing imidate and thioimidate diazeniumdiolates, compositions, uses thereof and method of making same The invention provides NO-- or NO- -releasing imidate, thioimidate, and amide diazeniumdiolates, in which the N2 O2- functional group is bonded to a carbon atom. The invention also provides compositions comprisi... | 01/06/2004 |
| 6627228 | Polymeric delivery agents and delivery agents compounds Polymeric delivery agents, delivery agent compounds and compositions comprising them which are useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.... | 09/30/2003 |
| 6566406 | Biocompatible crosslinked polymers Biocompatible crosslinked polymers, and methods for their preparation and use, are disclosed in which the biocompatible crosslinked polymers are formed from water soluble precursors having electrophilic and nucleophilic groups capable of reacting and cros... | 05/20/2003 |
| 6432417 | Cosmetic composition containing solid organic particles coated with a cationic polymer Cosmetic composition for the skin or skin appendages comprising a dispersion of solid organic particles in a binder and characterized in that at least a part of said organic particles is introduced in said composition in the form of particles having their... | 08/13/2002 |
| 6132706 | Methods of medical treatment for excess phosphate using guanidino-containing polymers The invention provides a physiologically acceptable polymer comprising a backbone to which are attached guanidino groups, the polymer having a minimum molecular weight of 10,000. The invention also extends to foodstuffs and pharmaceutical compositions com... | 10/17/2000 |
| 6084005 | Antimicrobial caries-detecting composition An antimicrobial caries-detecting composition, which comprises(i) water, a water-miscible solvent or a combination thereof, (ii) a dye capable of staining the caries-infected portions of teeth, and (iii) at least one antimicrobial agent.... | 07/04/2000 |
| 6007803 | Ionic polymers as toxin binding agents A method for treating pathogenic toxins in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising a cationic group attached to the polymer backbone. The polymer can be a homopolymer or a c... | 12/28/1999 |
| 5968499 | Polymeric compounds A polystyrene polymer crosslinked by 1.5% to 8% with divinylbenzene based on the total weight of the polymer and having a minimum weight average molecular weight of 10000 wherein 50 to 100% of the aromatic groups of the polystyrene are substituted by at l... | 10/19/1999 |
| 5888518 | Method for preventing and treating coccidiosis A method for preventing and treating parasitic infections in animals by administering a lysine analog, such as EACA, to the animals on a continuous basis. In the preferred embodiment, the method of the present invention is directed to preventing and treat... | 03/30/1999 |
| 5861437 | Polyphenylene ether resin A poly(phenylene ether) resin composed of structural units represented by the general formula: ##STR1## (wherein R1, R2 and R3 represent each alkyl, cycloalkyl, etc. or H (provided that two or more of R1, R... | 01/19/1999 |
| 5698190 | Polymeric compounds The invention provides a physiologically acceptable polymer comprising a backbone to which are attached guanidino groups, the polymer having a minimum molecular weight of 10,000. The invention also extends to foodstuffs and pharmaceutical compositions com... | 12/16/1997 |
| 5695749 | Composition containing cholestyramine and method of producing the same Cholestyramine and starch containing, oil-free compositions with excellent organoleptic features are obtained by mixing cholestyramine and grain starch in a weight ratio of 1:1.8 to 2.9 with the addition of grain bran as a filler and optionally an aroma s... | 12/09/1997 |
| 5667775 | Phosphate-binding polymers for oral administration Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.... | 09/16/1997 |
| 5635172 | Sustained release comfort formulation for glaucoma therapy Disclosed are nonstinging, sustained release ophthalmic formulations to control intraocular pressure in antiglaucoma therapy comprising a basic active, a cation exchange resin, and, inter alia, an acidic, mucomimetic polymer. Also disclosed are methods of... | 06/03/1997 |
| 5496545 | Phosphate-binding polymers for oral administration Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.... | 03/05/1996 |
| 5464612 | Solid preparation comprising ion exchanger and active agent (A) A clad powdery or granular preparation of a medicinally active ingredient and (B) a powdery or granular ion exchanger such as a cation exchange resin are blended to prepare a solid preparation. The active ingredient includes ଲ-lactam antibiotics... | 11/07/1995 |
| 5447717 | Cholesterol-lowering agents This invention relates to compounds of structural formula (I): ##STR1## which are squalene synthase inhibitors and thus useful as cholesterol lowering agents and antifungal agents. These compounds are also inhibitors of farnesyl protein transferass a... | 09/05/1995 |
| 5374422 | Ingestible [hydrophobic] polymeric amines useful for lowering blood cholesterol The invention is concerned with novel ingestible cross-linked homopolymers having functional groups consisting of linear or branched amines, of the formula: ##STR1## and their pharmaceutically acceptable salts of the formulae: ##STR2## wher... | 12/20/1994 |
| 5366724 | Ingestible polymeric amines for the lowering of blood cholesterol The invention is concerned with novel ingestible polymeric amines in linear or branched form of the formula: ##STR1## and their pharmaceutically acceptable salts of the formulae: ##STR2## wherein P represents a hydrophilic, cross-linked and dige... | 11/22/1994 |
| 5350584 | Spheronization process using charged resins The invention comprises a novel process for the spheronization of charged resins. Spherical multiparticlates are produced which range in size from 0.3 mm to 3 mm in diameter. The spherical particle product is microcrystalline-free. The process consists of... | 09/27/1994 |
| 5286481 | Method of reducing weight in mammals Described is a method of decreasing the weight in mammals to a desired level comprising orally administering thereto an effective weight reducing amount of a non-toxic anion exchange resin containing composition for a desired period of time to achieve a d... | 02/15/1994 |
| 5262167 | Edible, non-baked low moisture cholestyramine composition A highly palatable, low moisture non-baked cholestyramine composition has cholestyramine in stable admixture with a suitable carrier. The carrier is made up of a grain or flour, sugars and starch binder, and may also contain flavorings, preservative, and ... | 11/16/1993 |
| 5230885 | Polystyrene anion exchange polymer pharmaceutical composition Polystyrene polymers having a quaternised ammonium group and their use in a method of treatment of hypercholesterolaemia. A particular compound of the invention is (N,N-dimethyl-N-dodecyl-ammoniomethylstyrene-ethyl methacrylate-divinylbenzene co-polymer, ... | 07/27/1993 |
| 5137716 | Method of reducing weight in mammals Described is a method of decreasing the weight in mammals to a desired amount comprising the steps of ingesting an effective weight reducing amount of a cholestyramine for a desired period of time to achieve a desired weight reduction. Compositions useful... | 08/11/1992 |
| 4999189 | Sustained release oral suspensions Stable sustained release wax- and polymer-coated drug-ion exchange resin complexes especially useful in preparing oral suspensions are disclosed.... | 03/12/1991 |
| 4959219 | Coating barriers comprising ethyl cellulose Coatings for individual ion exchange resin particles comprised of (a) ethylcellulose and (b) corn oil or acetylated monoglycerides.... | 09/25/1990 |
| 4847077 | Controlled release pharmaceutical preparations Controlled release pharmaceutical preparations containing coated sulfonic acid cationic exchange resin drug complex particles, the resin particles having been treated, prior to coating, with about 15 to 25% by weight of glycerin, based on the combined wei... | 07/11/1989 |
| 4510128 | Resinate of a substituted carboxylic acid, the preparation and use thereof, and pharmaceutical compositions containing it A resinate of the formula ##STR1## wherein Am.sym. is a strongly basic copolymer of styrene and divinylbenzene which is in cationic form, said copolymer containing the sum of m+n quaternary ammonium groups and also containing, as main ... | 04/09/1985 |
| 4374932 | 5-ASA Drug delivery system The present invention relates to novel compounds for the prophylaxis and treatment of Inflammatory Bowel disease (IBD) via the administration of an effective amount in a suitable pharmaceutical dosage of a polymeric agent for releasing 5,5'-azobis-salicyl... | 02/22/1983 |
| 4344933 | Pharmaceutical composition with prolonged broncholytic and tocolytic activity Composition which has a prolonged broncholytic and tocolytic activity and consists of a compound of N,N'-bis-[2-(3',4'-dihydroxyphenyl)-2-hydroxyethyl]-hexamethylenediamine with a polystyrene which is crosslinked with divinylbenzene, contains sulphon... | 08/17/1982 |
| 3949068 | Pharmaceutical compositions Injectable emulsion containing a medicament, a thixotropic agent and membe-forming substance having ion-exchange properties. The membrane-forming substance being a polymerizable monomer which polymerizes by reaction with a polymerizing agent.... | 04/06/1976 |
